Received by email:

File: Vodis Pharmaceuticals Inc. - NewsRelease - November 21, 2016.pdf

2016-11-21 - News Release                  

                     Vodis announces Grant of Stock Options
November 21, 2016   Vancouver, British Columbia   Vodis Pharmaceuticals Inc. (CSE: VP /
FSE: 1JV) ("Vodis" or the "Company") announces that the Company has granted stock options
to directors, officers and consultants to purchase up to a total 5,150,000 common shares,
exercisable at a price of 26 cents per share, which is the closing price of the Company's shares
on November 18, 2016 which is the date of grant. The stock options are exercisable for five
years until November 18, 2021.

For further information, please contact:

Ivan Miliovski
Chief Executive Officer and Chief Operating Officer
Vodis Innovative Pharmaceuticals Inc.
8788 River Rd, Delta, V4G 1B4, Canada
Cell: 778-242-9677
Website: www.vodis.ca


The Canadian Securities Exchange has neither approved nor disapproved the contents of this
news release and accepts no responsibility for the adequacy or accuracy hereof.

Forward-Looking Information:

Certain information contained herein may constitute "forward-looking information" under Canadian
securities legislation. Generally, forward-looking information can be identified by the use of forward-
looking terminology such as "expects" or "it is expected", or variations of such words and phrases or
statements that certain actions, events or results "will" occur. Forward-looking statements are based on
the opinions and estimates of management as of the date such statements are made and they are
subject to known and unknown risks, uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be materially different from those
expressed or implied by such forward-looking statements or forward-looking information, including: the
use of proceeds of this financing. Although management of the Company has attempted to identify
important factors that could cause actual results to differ materially from those contained in forward-
looking statements or forward-looking information, there may be other factors that cause results not to
be as anticipated, estimated or intended. There can be no assurance that such statements will prove to
be accurate, as actual results and future events could differ materially from those anticipated in such
statements. Accordingly, readers should not place undue reliance on forward-looking statements and
forward-looking information. The Company does not undertake to update any forward-looking
statements or forward-looking information that is incorporated by reference herein, except as required
by applicable securities laws.

                                                                                              AC/4730360.1
                                                                                              AC/4748878.3




                                                                                              AC/4994529.2